Skip to main content

Dermatology

FDA Approvals, Biosimilars, Dermatology
Tremfya (Guselkumab), a Novel One-Press Patient-Controlled Injection, Approved for Moderate-to-Severe Plaque Psoriasis
Loretta Fala
Read More
Review Article, Dermatology, Original Research
The Challenge of Managing Atopic Dermatitis in the United States
Steven R. Feldman, MD, PhD; Linda S. Cox, MD; Lindsay C. Strowd, MD; Robert A. Gerber, PharmD, MA, MBA; Steven Faulkner, PharmD, MBA; Debra Sierka, PharmD; Timothy W. Smith, BA; Joseph C. Cappelleri, PhD; Mark E. Levenberg, DO
Stakeholder Perspective
Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges
Gary M. Owens, MD
Read More
Original Research, Rosacea, Dermatology
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study
Todd Williamson, PhD, MSc; Wendy Y. Cheng, MPhil, MPH; Nora McCormick, MSc; Francis Vekeman, MA
Stakeholder Perspective
There’s Room for Improvement in Rosacea Treatment
Gary M. Owens, MD
Read More
Dermatology, Perspectives
Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea
Read More
Dermatology
Combating Antibiotic Resistance a National Priority Reinforced by a New Executive Order
Read More
Dermatology, Rosacea
The Impact of Rosacea and Acne on a Patient’s Quality of Life Is Comparable to Other Chronic Conditions
Read More
Dermatology
Novel Rosacea Compound, Ivermectin Cream, Offers Unique Mechanism of Action
Read More
Dermatology
Ivermectin Cream Will Contribute Much to the Treatment of Patients with Rosacea: Interview with Dr Zoe Draelos
Read More
Dermatology
Addressing an Unmet Need in the Treatment of Patients with Papulopustular Rosacea: An Interview with Dr Linda Stein Gold
Read More
Dermatology
Investigational Agent Clears Papulopustular Rosacea by Tackling an Underlying Cause
Read More
Page 1 of 3
Results 1 - 10 of 28